Peritoneal carcinosis in ovarian cancer: Conventional imaging (CT-scan and MRI);Imagerie conventionnelle « péritonéale » des cancers de l'ovaire (scanner, IRM)

Bulletin du Cancer

Volumn 96, Issue 12, 2009, Pages 1155-1162

  Bailly, C ^a   Bailly Glatre, A ^a   Alfidja, A ^a   Vincent, C ^a   Dauplat, J ^b   Pomel, C ^b  

^a Centre Regional de Lutte Contre le Cancer Jean Perrin   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

CT; MRI; Ovary neoplasms; Peritoneal carcinomatosis

Indexed keywords

CANCER ADJUVANT THERAPY; CARCINOMATOUS PERITONITIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; INTESTINE WALL; MESENTERY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; RADIODENSITOMETRY; REVIEW; ARTICLE; ASCITES FLUID; CANCER INVASION; CARCINOMA; METHODOLOGY; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PHYSIOLOGY;

ASCITIC FLUID; CARCINOMA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 74049150307     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0981     Document Type: Review

References (34)

1. Meyers MA. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 1973 ; 119 : 198-206.
2. Woodward PJ, Hosseinzadeh K, Saenger JS. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics 2004 ; 24 : 225-46.
3. Holloway BJ, Gore ME, A'Hern RP, Parsons C. The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol 1997 ; 52 : 692-7.
4. Forstner R. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 2007 ; 17 : 3223-35.
5. Pereira A, Magrina JF, Rey V, Cortes M, Magtibay PM. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol 2007 ; 105 : 604-8.
6. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities. Report from the Radiological Diagnostic Oncology Group. Radiology 2000 ; 215 : 761-7.
7. Van Der Burg ME, Van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995 ; 332 : 629-34.
8. Kurtz AB, Tsimikas JV, Tempany CMC, Hamper UM, Arger PH, Bree RL, et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis. Report of the Radiology Diagnostic Oncology Group. Radiology 1999 ; 212 : 19-27.
9. Coakley FV, Choi PH, Gougoutas CA, Pothuri B, Venkatraman E, Chi D, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 2002 ; 223 : 495-9.
10. Buy JN, Moss AA, Ghossain MA, Sciot C, Malbec L, Vadrot D, et al. Peritoneal implants from ovarian tumors: CT findings. Radiology 1988 ; 169 : 691-4.
11. Akin O, Sala E, Moskowitz CS, Ishill N, Soslow RA, Chi DS, et al. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 2008 ; 248 : 511-7.
12. Taïeb S, Bonodeau F, Leblanc E, Vennin P, Fournier C, Besson P. Valeur prédictive du scanner abdominopelvien pour la chirurgie optimale des carcinomes de l'ovaire. Bull Cancer 2000 ; 87 : 265-72.
13. Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SS, Stern JL. Ovarian cancer: staging with CT and MR imaging. Radiology 1995 ; 197 : 619-26.
14. Pannu HK, Bristow RE, Montz FJ, Fishman EK. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics 2003 ; 23 : 687-701.
15. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993 ; 11 : 166-72.
16. Meyer JI, Kennedy AW, Friedman R, Ayoub A, Zepp RC. Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR 1995 ; 165 : 875-8.
17. Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 2000 ; 89 : 1532-40.
18. Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimaj cytoreductive surgery in woman with advanced ovarian cancer. Cancer 2004 ; 101 : 346-52.
19. Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 2005 ; 96 : 301-6.
20. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 2007 ; 25 : 384-9.
21. Kuhn W, Rutke S, Spathe K, Schmalfeldt B, Florak G, von Hundershausen B, et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage IIIC ovarian carcinoma. Cancer 2001 ; 92 : 2585-91.
22. Gemer O, Gdalevich M, Ravid M, Piura B, Rabinovich A, Gasper T, et al. A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surg Oncol 2009 ; 35 : 1109-12.
23. Salani R, Axtell A, Gerardi M, Holschneider C, Bristow RE. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol 2008 ; 108 : 271-5.
24. Bristow RE. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaisen. Gynecol Oncol 2009 ; 112 : 1-3.
25. Chi DS, Franklin CC, Levine DA, Akserod F, Sabbatini P, Jarnagin WR, et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 2004 ; 94 : 650-4.
26. Buist MR, Golding RP, Burger CW, Vermorken JB, Kenemans P, Schutter EMJ, et al. Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI. Gynecol Oncol 1994 ; 52 : 191-8.
27. Scherer C. Évaluation de la résécabilité des épithéliomas ovariens de stades avancés au moyen de la tomodensitométrie préopératoire. Thèse pour le doctorat en médecine, université de Clermont-Ferrand, 1998.
28. Pomel C, Jeyarajah A, Oram D, Shepherd J, Milliken D, Dauplat J, et al. Cytoreductive surgery in ovarian cancer. Cancer Imaging 2007 ; 7 : 210-5.
29. Low RN, Semelka RC, Worawattanakul S, Alzate GD. Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT in 164 patients. J Magn Reson Imaging 2000 ; 12 : 269-77.
30. Fujii S, Matsusue E, Kanasaki Y, Kanamori Y, Nakanishi J, Sugihara S, et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 2008 ; 18 : 18-23.
31. Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. J Comput Assist Tomogr 2007 ; 31 : 868-75.
32. Low RN. Magnetic resonance imaging in the oncology patient: evaluation of the extrahepatic abdomen. Semin Ultrasound CT MR 2005 ; 26 : 224-36.
33. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002 ; 20 : 1248-59.
34. Pomel C, Barton DPJ, McNeish I, Shepherd J. A statement for extensive primary cytoreductive surgery in advanced ovarian cancer. BJOG 2008 ; 115 : 808-10.